These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33754152)

  • 21. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fatal case of COVID-19-associated invasive pulmonary aspergillosis.
    Iwanaga Y; Kawanami T; Yamasaki K; Sakakibara H; Ikushima I; Ikegami H; Tahara M; Akata K; Mukae H; Yatera K
    J Infect Chemother; 2021 Jul; 27(7):1102-1107. PubMed ID: 33867266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis.
    de Brabander J; Boers LS; Kullberg RFJ; Duitman JW; Bos LDJ;
    Lancet Respir Med; 2022 Mar; 10(3):e25-e26. PubMed ID: 35122732
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.
    Blaize M; Mayaux J; Nabet C; Lampros A; Marcelin AG; Thellier M; Piarroux R; Demoule A; Fekkar A
    Emerg Infect Dis; 2020 Jul; 26(7):1636-1637. PubMed ID: 32343223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
    Fekkar A; Neofytos D; Nguyen MH; Clancy CJ; Kontoyiannis DP; Lamoth F
    Clin Microbiol Infect; 2021 Sep; 27(9):1376-1378. PubMed ID: 34192575
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
    Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
    Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges.
    Prattes J; Koehler P; Hoenigl M;
    Intensive Care Med; 2021 Nov; 47(11):1339-1340. PubMed ID: 34468820
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
    Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
    J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis.
    Permpalung N; Maertens J; Marr KA
    Lancet Infect Dis; 2021 Jun; 21(6):766-767. PubMed ID: 33662327
    [No Abstract]   [Full Text] [Related]  

  • 30. Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure.
    Fortarezza F; Boscolo A; Pezzuto F; Lunardi F; Jesús Acosta M; Giraudo C; Del Vecchio C; Sella N; Tiberio I; Godi I; Cattelan A; Vedovelli L; Gregori D; Vettor R; Viale P; Navalesi P; Calabrese F
    Mycoses; 2021 Oct; 64(10):1223-1229. PubMed ID: 34157166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply.
    Koehler P; White PL; Verweij PE; Cornely OA
    Lancet Infect Dis; 2021 Jun; 21(6):767-769. PubMed ID: 33662323
    [No Abstract]   [Full Text] [Related]  

  • 32. Subacute Aspergillosis "Fungal Balls" Complicating COVID-19.
    Patti RK; Dalsania NR; Somal N; Sinha A; Mehta S; Ghitan M; Seneviratne C; Kupfer Y
    J Investig Med High Impact Case Rep; 2020; 8():2324709620966475. PubMed ID: 33054445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Mitaka H; Kuno T; Takagi H; Patrawalla P
    Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
    Gangneux JP; Morcet J; Laviolle B; Dannaoui E; Timsit JF; Ruckly S; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Mar; 10(3):e27. PubMed ID: 35122731
    [No Abstract]   [Full Text] [Related]  

  • 35. Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatment.
    Tio SY; Williams E; Worth LJ; Deane AM; Bond K; Slavin MA; Sasadeusz J
    Intern Med J; 2021 Dec; 51(12):2129-2132. PubMed ID: 34939293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale.
    Worku DA
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmed Invasive Pulmonary Aspergillosis and COVID-19: the value of postmortem findings to support antemortem management.
    Santana MF; Pivoto G; Alexandre MAA; Baía-da-Silva DC; Borba MGDS; Val FA; Brito-Sousa JD; Melo GC; Monteiro WM; Souza JVB; Pinheiro SB; Ferreira LCL; Naveca FG; Nascimento VA; Corado ALG; Hajjar LA; Silva Neto JR; Siva GAV; Pasqualotto AC; Lacerda MVG
    Rev Soc Bras Med Trop; 2020; 53():e20200401. PubMed ID: 32638890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Singh S; Verma N; Kanaujia R; Chakrabarti A; Rudramurthy SM
    Mycoses; 2021 Sep; 64(9):1015-1027. PubMed ID: 34057252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes.
    de Almeida JN; Doi AM; Watanabe MJL; Maluf MM; Calderon CL; Silva M; Pasternak J; Koga PCM; Santiago KAS; Aranha LFC; Szarf G; da Silva Teles GB; Filippi RZ; Paes VR; Baeta M; Hamerschlak N; Mangueira CLP; Martino MDV
    Mycoses; 2022 Apr; 65(4):449-457. PubMed ID: 35174567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.